Friday, November 14, 2014 8:45:22 AM
"Vitamin Green could be a real success with the way we have planned and staggered entering the market. As it is ever-changing, we needed to feel confident internally that we are taking this in the right direction," commented Frank Ornelas, CEO of Vitamin Blue. "Jim brings a lot of experience and has been a valuable asset to us in determining and executing this plan."
Vitamin Green will finalize a beta launch roll out after closing beta signups for its website Greenstown.com. Those interested in a chance to be selected for the beta can sign up until November 15th at www.greenstown.com.
About Vitamin Blue, Inc. (www.vitaminblue.com):
Vitamin Blue designs, develops, produces and distributes water boardsports apparel, accessories and related products. Founded in 1999, the Costa Mesa, California based company in part of the consumer goods sector and non-durables industry.
Forward Looking Statements:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Any statements made in this press release that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements. Forward-looking statements include information concerning possible or assumed future results of operations, including descriptions of our business plans and strategies. Although we believe that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect our actual financial results or results of operations and could cause actual results to differ materially from those expressed in the forward-looking statements, including, without limitation, the factors described under "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" of our Securities and Exchange Commission filings.
Contact
Vitamin Blue
contact@vitaminblue.com
SOURCE: Vitamin Blue, Inc.
mailto:contact@vitaminblue.com
(C) 2014 Marketwire L.P. All rights reserved.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM